KYBELLA® Submental Fat (Under Chin) Treatment
What is Kybella?
Kybella is a non-surgical alternative to fat reduction in the neck for individuals who do not want an invasive procedure such as liposuction. Kybella is the first FDA-approved injectable drug that significantly reduces the appearance of submental fat, otherwise known as a double chin. It is safe, non-invasive, effective, and long lasting.
How does Kybella work?
Kybella is synthetic deoxycholic acid. Deoxycholic acid is a naturally occurring molecule in the body that helps break down and absorb fat. When injected into the fat beneath the chin, Kybella destroys fat cells permanently. Once destroyed, these cells can no longer store or accumulate fat, so further treatment is not expected once you reach your desired aesthetic goal. Fat destroyed by the injections is flushed from the body naturally, resulting in a gradual reduction of excess fat that causes a double chin.
What is the procedure like?
The procedure takes about 20 minutes. The area will first be cleansed, marked out, and anesthetized with a few injections of lidocaine anesthetic. Kybella is then injected into the area at 10-30 sites following a grid like pattern. The number of injections is determined by how much submental fullness you have. These injections are nearly painless. A dressing is applied for 1-2 days after the procedure to reduce swelling and bruising.
What can I expect after my treatment?
The most common side effects are swelling, bruising, pain, numbness, redness, and areas of firmness in the treatment area. As fat cells are destroyed over 4 to 8 weeks, you will notice gradual reduction in submental fullness. Most patients see improvements after the first treatment, but a series of 2 to 4 or more (up to 6) injection sessions are needed to achieve the best possible long lasting results.
Who should not undergo Kybella treatment?
Patients who should not be treated with Kybella include people under the age of 18, pregnant or lactating women, and people who have swallowing problems. Patients over the age of 65 can be treated, but low doses are generally used. Kybella should be used with caution in patients with bleeding abnormalities or who are currently being treated with antiplatelet or anticoagulant therapy, such as aspirin or Coumadin (warfarin), as excessive bruising in the treatment area may occur. Kybella should not be used in anyone who has an infection in the area to be treated.